IBM Completes Acquisition of HRL Laboratories to Expand Multi-Modality Quantum Roadmap

IBM (NYSE: IBM) has officially completed its acquisition of Malibu-based research and development institution HRL Laboratories, LLC (HRL). The transaction brings HRL’s deep expertise in silicon-spin qubits, quantum sensing, cryogenics, and advanced materials under IBM’s quantum umbrella, complementing IBM’s established leadership in superconducting qubit architectures.

Dual-Track Hardware Scaling and Wafer Foundry Integration

The closing of the transaction establishes a dual-track hardware strategy for IBM, combining superconducting circuits with silicon quantum dots:

• Silicon-Spin Qubit Capability: HRL’s decades-long heritage in semiconductor quantum dot engineering enables IBM to leverage CMOS-compatible manufacturing techniques. This creates parallel research and manufacturing pathways for high-density, multi-qubit processor scaling.
• Anderon Foundry Alignment: HRL’s silicon fabrication processes will integrate into Anderon, IBM’s pure-play quantum wafer foundry established earlier this year. This alignment accelerates R&D learning cycles across substrate design, interconnects, control electronics, and cryogenic packaging.
• Quantum Sensing & Materials Science: The acquisition expands IBM’s portfolio into quantum sensing, high-efficiency detectors, and novel quantum materials for defense, industrial, and medical applications.